Cutaneous leishmaniasis in rheumatoid arthritis;Leishmaniose cutanée au cours de la polyarthrite rhumatoïde

Revue de Medecine Interne

Volumn 30, Issue 7, 2009, Pages 609-612

  Hachicha, I ^a   Sellami, M ^a   Fourati, H ^a   Akrout, R ^a   Hdiji, N ^a   Baklouti, S ^a  

^a HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

Cutaneous leishmaniasis; Immunodepression; Rheumatoid arthritis; Treatment

Indexed keywords

MEGLUMINE ANTIMONATE; METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION SENSITIVITY; RHEUMATOID ARTHRITIS; RISK FACTOR; SKIN LEISHMANIASIS; TREATMENT RESPONSE;

ADULT; ANTIPROTOZOAL AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LEISHMANIASIS, CUTANEOUS; MEGLUMINE; METHOTREXATE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PREDNISONE;

EID: 67649403180     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.11.015     Document Type: Article

References (22)

1. Vardy D.A., Cohen A., Kachco L., Zvulunov A., and Fran Kenburg S. Relapse of cutaneous leishmaniasis in a patient with an infected subcutaneous rheumatoid nodule. Br J Dermatol 141 (1999) 914-917
2. Dedet J.P. Leishmanies, leishmanioses. Biologie clinique et thérapeutique. Encycl Med Chir Mal Infect (2001) 8-506-A-10
3. Hepburn N.C. Cutaneous leishmaniasis: current and future management. Expert Rev Anti Infect Ther 1 (2003) 563-570
4. Murray H.W., Berman J.D., Davies C.R., and Saravia N.G. Advances in leishmaniasis. Lancet 366 (2005) 1561-1577
5. Direction des soins de santé de base. Bulletin épidémiologiques du ministère de la Santé Publique (Tunisie) 2000.
6. Ben Ismail R., Ben Said M., and Ben Rachid M.S. Leishmaniasis: status in Tunisia. Natoi-Asi Monograph series of leishmaniasis: the current status and new strategies for control (1989), Plenum Press, New York pp. 39-45
7. Khaled M.R., and Khan A.A. Unusual clinical variants of cutaneous leishmaniasis in Pakistan. Br J Dermatol 139 (1998) 111-113
8. Zahaf A. La leishmaniose cutanée zoonotique en Tunisie. Problème d'actualité. Bull Soc Pathol Exot 78 (1985) 758
9. Alrajhi A.A., Ibrahim E.A., Devol E.B., Kharrat M., Faris R.M., and Maguire J.H. Fluconazole for the treatement of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 346 (2002) 891-895
10. Couppie E., Clyti M., Sobesky F., Bissuel F., Del giudice P., Sainte-Marie D., et al. A comparative study of cutaneous leishmaniasis in HIV infected patients and non HIV infected patients in French Guiana. Br J Dermatol 151 (2004) 1165-1171
11. Agarawel S.K., and Marshall J.R. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 21 (2001) 147-155
12. Grenblat C.L., Schlein Y., and Schnur L.F. Leishmaniasis in Israel and vicinity (1985), Elsevier, Amsterdam pp. 415-26
13. Klaus S.N., and Frankenburg S. Leishmaniasis and other skin infections (1999), Mc Graw Hill, New York
14. ® en intralésionnel dans le traitement de la leishmaniose cutanée. Med Mal Infect 36 (2006) 226-228
15. Minodier P., and Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis 5 (2007) 150-158
16. Berman J. Clinical status of agents being developed for leishmaniasis. Expert Opin Investig Drugs 14 (2005) 1337-1346
17. Alvar J., Croft S., and Olliaro P. Chemotherapy in the treatment and control of leishmaniasis. Adv Parasitol 61 (2006) 223-274
18. Buffet P., Caumes E., and Gentilini M. Traitement des leishmanioses cutanées localisées. Ann Dermatol Venereol 121 (1994) 503-511
19. D'Oliviera A., Roberto P., and Machado L. Evaluating the efficacy of the treatment of cutaneous leishmaniasis. Int Dermatol 36 (1997) 938-946
20. Schwartz E., Hatz C., and Blum J. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis 6 (2006) 342-349
21. Jundid A.J.N. Treatement of cutaneous leishmaniasis with infrared heat. Int J Dermatol 25 (1986) 470-472
22. Roussel M., Nacher M., Fremont G., Rotureau B., and Clyt E. Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana. Ann Trop Med Parasitol 100 (2006) 307-314